Protective role of magnesium in cardiovascular diseases: A review

Molecular and Cellular Biochemistry

Volumn 238, Issue 1-2, 2002, Pages 163-179

  Chakraborti, S ^a   Chakraborti, T ^b   Mandal, M ^a   Mandal, A ^a   Das, S ^a   Ghosh, S ^c  

^a UNIVERSITY OF KALYANI   (India)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c CALCUTTA NATIONAL MEDICAL COLLEGE   (India)

Author keywords

Adenosine; Ageing; Alcohol; Antioxidants; Calcium; Cardiovascular diseases; Coronary heart diseases; Diabetes; Gene expression; Magnesium; Oxidants; Potassium; Signal transduction; Sodium

Indexed keywords

ACTIN; ALCOHOL; CALCIUM ION; CATECHOLAMINE; CONTRACTILE PROTEIN; GROWTH FACTOR; MAGNESIUM; MAGNESIUM ION; MYOSIN; OXYGEN; OXYGEN RADICAL; POTASSIUM ION; SODIUM ION; TROPONIN C; OXIDIZING AGENT; PROTECTIVE AGENT;

ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ATHEROSCLEROSIS; BINDING COMPETITION; CARDIOPLEGIA; CARDIOVASCULAR DISEASE; CELL MEMBRANE PERMEABILITY; CELL TRANSPORT; CLINICAL STUDY; CONGESTIVE HEART FAILURE; CORONARY ARTERY CONSTRICTION; DIABETES MELLITUS; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; ELECTROLYTE DISTURBANCE; EXPERIMENTATION; HEART ARRHYTHMIA; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HYPERTENSION; HYPOKALEMIA; HYPOMAGNESEMIA; ISCHEMIC HEART DISEASE; MAGNESIUM METABOLISM; MEDICAL RESEARCH; MORBIDITY; MORTALITY; NONHUMAN; NUTRIENT SUPPLY; NUTRITIONAL DEFICIENCY; OXYGEN TRANSPORT; PATHOGENESIS; RAT; REVIEW; SIGNAL TRANSDUCTION; SUDDEN DEATH; CHANNEL GATING; GENETICS; MAGNESIUM DEFICIENCY; METABOLISM; PATHOLOGY;

ANIMALIA;

CARDIOVASCULAR DISEASES; HUMANS; ION CHANNEL GATING; MAGNESIUM; MAGNESIUM DEFICIENCY; OXIDANTS; PROTECTIVE AGENTS; SIGNAL TRANSDUCTION;

EID: 0036718379     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1019998702946     Document Type: Review

References (113)

1. Chronic heart failure and micronutrients
2. 2+ accumulation during reoxygenation of rat cardiomyocytes
3. Myocardial protection during ventricular fibrillation by reduction of proton-driven sarcolemmal sodium influx
4. Dietary intake and bioavailability of trace elements
5. Dietary and physiological studies to investigate the relationship between calcium and magnesium signalling in the mammalian myocardium
6. New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system. I. Clinical aspects
7. Problems with potassium and magnesium in diuretic-treated patients
8. Is low magnesium concentration a risk factor for coronary heart disease?
9. Intravenous magnesium therapy in acute myocardial infarction
10. Magnesium level in drinking water: Its importance in cardiovascular risk
11. Geographical relation between the chemical nature of river water and death rate from apoplexy
12. Relations between mortality from cardiovascular disease and treated water supplies
13. Magnesium interrelationships in ischemic heart disease: A review
14. The importance of dietary magnesium with particular reference to humans
15. Health aspects of hard and soft waters
16. Ischemic heart disease and soil magnesium in Finland
17. Suomen peltojen viljavuudesta II (on the fertility of the cultivated soils in Finland) Helsinki
18. Oral magnesium supplementation restores the concentration of magnesium, potassium and sodium potassium pumps in skeletal muscle of patients receiving diuretic treatment
19. Myocardial injury in magnesium deficiency
20. Hypertensive vascular disease
21. Effect of magnesium on calcium responses to vasopressin in vascular smooth muscle cells to spontaneously hypertensive rats
22. Effect of oral magnesium supplementation on blood pressure, platelet aggregation and calcium handling in deoxycortisone acetate induced hypertension in rats
23. Disturbance of magnesium metabolism in the spontaneously hypertensive rat
24. The appearance of the exhausted platelets due to a duration of hypertension in stroke prone spontaneously hypertensive rats
25. The loss of endothelium dependent vascular relaxation in hypertension
26. Time courses of the change in blood pressure level in magnesium deficient Wistar rats
27. Clinical manifestations of magnesium deficiency
28. Decreases by magnesium of QT dispersion and ventricular arrhythmias in patients with acute myocardial infarction
29. Time-course of the change in blood pressure level in magnesium-deficient Wistar rats
30. The role of calcium in the stimulation of aldosterone production by adrenocorticotropin, angiotensin II, and potassium in isolated glomerulosa cells
31. Effects of magnesium on the renin-angiotensin-aidosterone system in human subjects
32. Regulation of aldosterone secretion
33. Magnesium depletion impairs myocardial carbohydrate and lipid metabolism and cardiac bioenergetics and raises myocardial calcium content in vivo: Relationship to etiology of cardiac diseases
34. Hypomagnesemia is linked to low serum HDL-cholesterol irrespective of serum glucose values
35. Effect of acute magnesium deficiency (MgD) on aortic endothelial cell (EC) oxidant production
36. 2 in pulmonary endothelium
37. 2 in pulmonary endothelium
38. 2 in pulmonary smooth muscle cells
39. Targets of oxidative stress in the cardiovascular system: An overview
40. Oxidant-mediated activation of mitogen activated protein kinase and nuclear transcription factors in the cardiovascular system: An overview
41. Complement activation in heart diseases: Role of oxidants
42. β-adrenergic mechanisms in cardiac diseases : A perspective
43. 2+ concentration in isolated rat hearts via beta-adrenergic and muscarinic receptors
44. Cell magnesium transport and homeostasis: Role of intracellular compartments
45. i alpha levels in the rat heart after myocardial infarction
46. Deficient production of cyclic AMP: Pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure
47. Characterization of the promoter of the human Gi2 alpha-subunit gene
48. i alpha-2 in rat heart
49. 2+ during metabolic stimulation of rat cardiac myocytes and perfused hearts
50. 2+ transport systems
51. 2+ by rat liver mitochondria
52. + across the rat liver mitochondrial membrane
53. Studies of the energy-dependent uptake of divalent metal ions by beef heart mitochondria
54. 2+ in rat heart mitochondria
55. Magnesium. An update on physiological, clinical and analytical aspects
56. 2+ influx
57. 2+ release channel from cardiac sarcoplasmic reticulum
58. 2+ ions
59. 2+ buffering through a Ca-dependent mechanism in cardiomyocytes
60. Magnesium restores the altered force-frequency relationship in failing human myocardium
61. Magnesium and potassium interrelationships in cardiac arrythmias
62. Effects of intracellular magnesium on calcium, potassium and chloride channels
63. 2+ block
64. Magnesium ions in cardiac function. Regulator of ion channels and second messengers
65. Magnesium-deficiency potentiates free radical production associated with postischemic injury to rat hearts: Vitamin E affords protection
66. Modulation of cytokines and myocardial lesions by vitamin E and chloroquine in a Mg-deficient rat model
67. Influence of magnesium deficiency on the bioavailability and tissue distribution of iron in the rat
68. Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin
69. Antiarrhythmic effect of magnesium sulfate against occlusion-induced arrhythmias and reperfusion-induced arrhythmias in anesthetized rats
70. Effects of extracellular magnesium manipulation on reperfusion-induced arrhythmias and myocardial ion shifts in isolated ischemic reperfused rat hearts
71. Protein interactions with detrimental metal ions
72. Changes in Cu, Zn-superoxide dismutase, cytochrome c oxidase, glutathione peroxidase and glutathione transferase activities in copper-deficient mice and rats
73. Magnesium activated adenosine formation in intact perfused heart: Predominance of ecto 5′-nucleotidase during hypermagnesemia
74. Glibenclamide reduces the coronary vasoactivity of adenosine receptor agonists
75. 2 pretreatment
76. Intracellular magnesium homeostasis is involved in the functional recovery of preconditioned rat heart
77. Magnesium-deficiency-enhanced post-ischemic myocardial injury is reduced by substance P receptor blockade
78. Cytoprotective function of nitric oxide: Inactivation of superoxide radicals produced by human leukocytes
79. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide
80. Substance P induces the expression of intercellular adhesion molecule-1 on vascular endothelial cells and enhances neutrophil transendothelial migration
81. 2+ and vascular contractility
82. Magnesium and potassium supplementation in the prevention of diabetic vascular disease
83. Insulin modulation of intracellular free magnesium in heart: Involvement of protein kinase C
84. 2+ Uptake in liver
85. Cardiovascular effects of alcohol
86. Wine, alcohol, platelets, and the French paradox for coronary heart disease
87. The effects of alcohol on the heart
88. Tissue concentrations of magnesium in rats receiving various dosages of ethanol
89. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine
90. Effects of alcohol on the myocardium. I. An analysis of the effects of ethanol on the bullfrog myocardium
91. Membrane actions of ethanol on rabbit sinoatrial node studied by voltage clamp method
92. Magnesium modulates contractile responses of rat aorta to thiocyanate: A possible relationship to smoking-induced atherosclerosis
93. Effect of chronic smoking on endothelium-dependent vascular relaxation in humans
94. Mechanisms of in vitro cardioprotective action of magnesium on the aging myocardium
95. Magnesium cardioplegia reduces cytosolic and nuclear calcium and DNA fragmentation in the senescent myocardium
96. Aging impairs functional, metabolic and ionic recovery from ischemia-eperfusion and hypoxia-reoxygenation
97. Magnesium cardioplegia enhances mRNA levels and the maximal velocity of cytochrome oxidase I in the senescent myocardium during global ischemia
98. Calcium content and force of drug-induced contractions of arterial muscle during recovery in vitro
99. 2+ modulates membrane lipids in vascular smooth muscle: A link to atherogenesis
100. Myocardial injury in magnesium deficiency
101. Calcium handling and cell contraction in rat cardiomyocytes depleted of intracellular magnesium
102. 2+ inhibition of cardiac ryanodine receptor by palmitoyl coenzyme A
103. Effects of magnesium infusion on thrombolytic and non-thrombolytic treated patients with acute myocardial infarction
104. Is low magnesium concentration a risk factor for coronary heart disease? The atherosclerosis risk in communities (ARC) study
105. Magnesium inhibition of ryanodine-receptor calcium channels: Evidence for two independent mechanisms
106. Effects of extracellular magnesium and beta adrenergic stimulation on contractile force and magnesium mobilization in the isolated rat heart
107. Red cell magnesium concentration in cor pulmonale. Correlation with cardiopulmonary findings
108. 2+ in the patients with diabetes and coronary heart disease